SlideShare una empresa de Scribd logo
1 de 73
Introduction to
  Pharmacology

Practicum of Health Science
  Technology 2009 - 2010
What is Pharmacology?
• Pharmaceutical derived from the
  Greek word for poison
• A science that studies drug effects
  within a living system
• Deals with all drugs used in society
  today, legal or illegal, including
  street, prescription, and non-
  prescription or over –the-counter
  medications
Drug
• A drug is defined as any
  substance used in the diagnosis,
  cure, treatment, or prevention of
  a disease or condition
Drug Names

• Chemical Name
• Generic Name
• Trade Name
Chemical Name
• Describes its molecular structure
  and distinguishes it from other
  drugs
Generic name
• Determined by the
  pharmaceutical company along
  with a special organization
  known as the U.S. Adopted
  Names Council (USAN)
Trade Name
• Or brand name- the
  manufacturer selects alone…can
  become a registered trademark.
  They are the only one who can
  advertise and market the drug
  under that name
How is the Trade Name Chosen?

• The particular spelling of a brand
  name drug is proposed by a
  manufacturer for one of several
  reasons.
1. To indicate the disease
  process being treated

• Azmacort- treats asthma

• Rythmol- treats cardiac
  arrhythmias
2. To simplify the generic
             name

• Pseudoephedrine to Sudefed

• Haloperidol to Haldol

• Ciprofloxacin to Cipro
3. To indicate the duration


• Slow-K slow release
  potassium supplement
Prescription Drugs
• Or legend drugs
• Means in order to obtain drug, you
  must have a legal prescription
Non-Prescription Drugs
• Or Over-the-Counter (OTC) drugs
• Drug that may be purchased without
  a prescription
Sources of Drugs
Drugs and biological products have
  been identified or derived from four
  main sources:
• Plants
• Animals and Humans
• Minerals and Mineral Products
• Synthetic or Chemical Substances
  Made in the Laboratory
Active Constituents of Plant
   Drugs

• The leaves, roots, seeds, and other
  parts of plants may be dried or
  otherwise processed for use as a
  medicine and , as such, are known as
  Crude drugs.
• Their therapeutic effect is produced
  by the chemical substances they
  contain
Active Constituents of Plant
   Drugs

• When the pharmacologically active
  parts are separated from the crude
  preparation, the resulting substances
  are more potent and usually produce
  effects more reliably than the crude
  drug.
Active Constituents of Plant
  Drugs

• Some of the types of
  pharmacologically active compounds
  found in plants, grouped according to
  their physical and chemical
  properties, are alkaloids, glycosides,
  gums and oils
Alkaloids
• Organic compounds that are alkaline
  in nature and are chemically
  combined with acids in the
  laboratory to form water – soluble
  salts
• Example – Morphine Sulfate
Glycosides
• Active plant substances that, on
  hydrolysis, yield sugar plus one or
  more additional active substances
• The sugar is believed to increase the
  solubility, absorption, permeability,
  and cellular distribution of the
  glycoside
• Example - Digoxin
Gums
• Plant exudates
• When water is added, some of them will swell and
  form gelatinous masses
• Others remain unchanged in the GI tract, where
  they act as hydrophilic colloids
• They absorb water, form watery bulk, and exert a
  laxative effect
• Are also used to soothe irritated skin and mucous
  membranes
• Example – Psyllium seeds are a natural laxative
  gum
• Example – Carboxymethylcellulose are synthetic
  colloids
Oils
•  Highly viscous liquids and are
   generally of two kinds
1. Volatile
2. Fixed
Volatile Oil
• Imparts an aroma to a plant
• Because of their pleasant odor and
  taste, these oils are frequently used as
  flavoring agents
• Evaporate easily
• Typically non-greasy
• Example – Peppermint
Fixed Oil
• Generally greasy and do not
  evaporate easily
• Example – Castor Oil
Drug Classification
•  Can be approached from two
   perspectives
1. Clinical Indication
   Example – Bronchodilator Drugs
2. Body System
   Example – Drugs Affecting the
   Nervous System
Controlled Substances
• Drugs which are classified according to
  their use and abuse potential
• Term originated in 1970 as a result of the
  Controlled Substances Act which was
  developed to provide increased research
  into, and prevention of, drug abuse and
  drug dependence; to provide treatment
  and rehabilitation of drug abusers and
  drug dependent persons; and to improve
  the administration and regulation of the
  manufacturing, distributing, and
  dispensing of controlled substances
Schedule of Controlled
   Substances
• Classifies drugs solely according to
  their use and abuse potential
• Drugs are classified into numbered
  levels, or schedules, from Schedule I
  to Schedule V
• Drugs with the highest abuse
  potential are placed in Schedule I;
  those with the lowest potential for
  abuse are in Schedule V
Investigational Drugs
• The multibillion dollar
  pharmaceutical industry is constantly
  screening substances with potential
  to market as new drugs
• Prospective drugs take anywhere
  from 5 – 10+ years and huge amounts
  of money to progress through the
  Food and Drug Administration
  required testing sequence
Drug Design

• New drugs are discovered in one of
  two ways

1. Totally new chemical substance

2. Derived from molecular
  manipulation of a current drug
Drug Design

• Until recently,designing a new
  drug by changing the
  molecular structure of an
  existing drug was a very slow
  process of trial and error
Recombinant DNA technology
  Gene splicing or genetic engineering


• Aided by computer design and use of
  enzymes, researchers are able to
  remove DNA chemically from one
  organism and transplant into other
Testing


• In vitro- in glass

• In vivo- in living

• Many guidelines set by FDA
Animal Phase

• Precedes human testing
• Watching for toxic effects,side
  effects, addictions, cancerous
  tumors or fetal deformities
Animal Phase

• Calculating the Therapeutic
  Index (TI) …. The difference
  between the dosage that
  produces a Therapeutic Effect
  and the dosage that produces a
  Toxic Effect
Animal Phase
• NOT always a reliable
  indicator of how well a drug
  will perform in humans.
Animal Phase

•   Modes of Absorption
•   Distribution
•   Metabolism
•   Excretion
Human Testing
• Occurs in three phases
• All participants must be given
  informed consent
Informed Consent
• Written consent to an experimental
  procedure by an individual after he
  or she has been given a careful
  explanation of the purpose of the
  study, procedure to be used, the
  expected effects, and the risks
  involved
Nuremberg Code
• Developed under the guidance of
  American physicians as a result of
  the post World War II trials at
  Nuremberg of Nazi physicians who
  had conducted experiments on
  political prisoners without their
  consent
The Code states:

• Truly voluntary consent of the
  human subject is critical
• The experiment must be proved to be
  valid or made possible only through
  the use of human subjects
• The results and risks are justified by
  the study
The Nuremberg Code

• Unnecessary suffering, death, or
  disability will be avoided
• The experiment will be conducted in
  a careful and professional manner by
  scientifically qualified persons
• The subject or the investigator may
  terminate the experiment at any
  point that it is felt unendurable or
  impossible
Human Testing: Phase I

• Healthy volunteers used to study
  absorption, distribution, metabolism,
  and routes of elimination or
  excretion
• Safe dose range, evaluate side effects
  and establish a correct dosage for
  therapeutic effect.
• Blood tests, urine analysis, vital signs,
  and specific monitoring tests are
  performed during this phase
Human Testing: Phase II

• Drug is administered at gradually
  increasing dosages to selected
  individuals with the targeted disease
• During this phase individuals are
  closely monitored for drug
  effectiveness and for side effects
• If no serious side effects occur, the
  study will progress to Phase III
Human Testing: Phase III

•   Drug is ready for testing at various
    different centers in larger numbers
    than previous phases
•   Standard protocols have been
    established to be followed at each
    center
Human Testing: Phase III

• Objectives for this phase are:
  - Determination of clinical
  effectiveness
  - Drug Safety determination
  - Establishment of tolerated dosage
  or dosage range
Human Testing: Phase
  III
              • Group A
• all patients with the disorder
  receive the new drug being
  studied
• results compared to next two
  groups for side effects and ability
  to treat disorder
Human Testing: Phase
            III
              • Group B
• all patients have disorder meant
  to be treated by new drug
• all patients receive a placebo and
  results are compared to other 2
  groups
Human Testing: Phase
           III
              • Group C
• all patients have disorder meant
  to be treated by new drug
• patients will be treated by
  another drug currently being
  used to treat disorder
FDA Approval

• After reviewing all
  documentation on the safety
  and effectiveness of the new
  drug
• May be protected by a patent
  for up to 17 years
Pregnancy Safe Categories

• Before using any drug during pregnancy,
  the expected benefits should be considered
  against the possible risks to the fetus
• The FDA has established a scale to indicate
  drugs that may have documented
  problems in animals and/or humans
  during pregnancy
• For many drugs, this information is
  unknown
Category A

• Adequate and well – controlled
  studies indicate no risk to the fetus in
  the first trimester of pregnancy, and
  there is no evidence of risk in later
  trimesters.
Category B

• Animal reproduction studies indicate
  no risk to the fetus and there are no
  well – controlled studies in pregnant
  women
Category C

• Animal reproduction studies have
  reported adverse effects on the fetus;
  and there are no well – controlled
  studies in humans, but potential
  benefits may indicate use of the drug
  in pregnant women despite potential
  risks
Category D

• Positive human fetal risk has been
  reported in data from investigational
  or marketing experience, or human
  studies
• Considering potential benefit versus
  risk may, in selected cases, warrant
  the use of these drugs in pregnant
  women
Category X

• Fetal abnormalities reported and
  positive evidence of fetal risk in
  humans is available from animal
  and/or human studies
• The risks involved outweigh the
  potential benefits
• These drugs should NOT be used in
  pregnant women
Medication Orders

•   Verbal Order
•   Telephone Order
•   Incomplete Order
•   Incorrect or Inappropriate Order
•   Invalid Order
•   Orders for Unfamiliar Drugs
Medication Order

Should Include:
• Name of patient medication is to be
  administered
• Medication name
• Dosage
• Route
• Time of administration
• Signature of prescriber
Verbal Order

• Given or received verbally
• All orders must be written prior to
  administration
Telephone Order

• An order given over the telephone
• Prescriber must sign order within
  48h of administration
• Person receiving the orders should
  listen to the order, write it down,
  then repeat it back to the prescriber
  completely for verification prior to
  ending the call
Incomplete Order

• Orders that are not complete in
  patient name, medication name, dose,
  route, time, or signature must be
  clarified and corrected BEFORE
  administration
Incorrect or Inappropriate
   Order
• May be judged by the administrator as
  being incorrect, or inappropriate for the
  client it is ordered
• It is the administrator’s RIGHT and
  RESPONSIBILITY to question ANY
  order or action that is potentially harmful
  to the patient
• To carry out an order that one knows to
  be incorrect constitutes negligence
• To change an order by modifying any part
  of it without the consultation with the
  prescriber is ILLEGAL
Incorrect or Inappropriate
   Order
• Validate the order by consulting an
  authoritative reference source such as a
  drug reference book
• If the order is apparently incorrect,
  objectively report the conflicting facts and
  discuss it with the prescriber
• If the prescriber still wants the medication
  given as ordered after the objections have
  been stated the immediate supervisors, or
  managers should be sought
Incorrect or Inappropriate
  Order
• If the prescriber decides to
  administer the medication themselves
  make sure the documentation reflects
  the objections and actions that have
  taken place
Invalid Order

• Orders signed by medical students,
  unlicensed interns and medical
  residents; and physicians who do not
  have prescriptive authority at your
  institution should not be
  administered until the order is
  verified and clarification is made
Order for Unfamiliar Drug

• Prior to administration of an unfamiliar
  medication, the administrator should
  “Look It Up” or “Ask the Pharmacists”!
• Administration of an unfamiliar
  medication while remaining in ignorance
  of its actions, its intended effects and side
  effects, and its adverse reactions is
  considered negligence if it results in harm
  to the patient
5 Rights of Drug Administration

1.   Right Medication
2.   Right Patient
3.   Right Dosage
4.   Right Route
5.   Right Time
Medical Terminology
Instructions

Define the following terms in your
 interactive note book. Utilize KIM
 technique with the K = Key word/
 key term; I = Information/
 Definition; and M = Memory Cue –
 something that will help you to
 remember the term. Maybe a
 picture, word, or phrase.
Terms

•   Pharmacology        •   Alkaloid
•   Pharmacopeia        •   Glycoside
•   Drug                •   Gums
•   Chemical Name       •   Hydrophilic
•   Generic Name        •   Water – soluble
•   Trade Name          •   Volatile oil
•   Prescription Drug   •   Fixed oil
•   Non-prescription
    Drug
Terms

• Controlled           •   Toxic effect
  Substance            •   Alkaline
• Therapeutic Index    •   Hydrolysis
• Therapeutic effect   •   Distribution
• Informed Consent     •   Metabolism
• Crude drugs          •   Excretion
Medical Abbreviations
• USAN – United States Adopted Name
  Council
• OTC – Over – the – Counter
• PDR – Physician’s Desk Reference
• FDA – Food and Drug Administration
• DEA – Drug Enforcement Administration
• TI – Therapeutic Index
• VO – Verbal order
• TO – Telephone order
VIP of the Week
Alexander Fleming

Instructions: Research this person and write
  the following in your interactive notebook.
• Who is he? Describe him as a person.
• What significance did he have to medicine,
  science, or health care?
• How can you utilize his contribution in
  your profession?
• How did his contribution affect the world?

Más contenido relacionado

La actualidad más candente

Medication administration.ppt
Medication administration.pptMedication administration.ppt
Medication administration.pptTashfeen Ahmad
 
Introduction Medication Administration
Introduction Medication AdministrationIntroduction Medication Administration
Introduction Medication AdministrationNaveen Kumar Sharma
 
New drug development naser
New drug development naserNew drug development naser
New drug development naserNaser Tadvi
 
New Drug Development and Review
New Drug Development and ReviewNew Drug Development and Review
New Drug Development and Reviewyllin
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacologyLikith `HV
 
Pharmacology 1
Pharmacology 1Pharmacology 1
Pharmacology 1cqpate
 
Introduction to pharmacology 1
Introduction  to pharmacology 1Introduction  to pharmacology 1
Introduction to pharmacology 1Mr. Dipti sorte
 
Phase clinicaltrial
Phase clinicaltrialPhase clinicaltrial
Phase clinicaltriallillibabu
 
Introduction to clinical pharmacology (RUD)
Introduction to clinical pharmacology (RUD)Introduction to clinical pharmacology (RUD)
Introduction to clinical pharmacology (RUD)Mirbek Nyshanbaev
 
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...MOHAMMAD NOUR AL SAEED
 
6 rules of drug administration
6 rules of drug administration6 rules of drug administration
6 rules of drug administrationakusoleha
 
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...Prof. Dr. Basavaraj Nanjwade
 
Introduction to pharmacology in nursing
Introduction to pharmacology in nursingIntroduction to pharmacology in nursing
Introduction to pharmacology in nursingSANDEEP MEWADA
 
1. introduction, route of administration
1. introduction, route of administration 1. introduction, route of administration
1. introduction, route of administration Dr.Manish Kumar
 
Clinical trials by khadga
Clinical trials by  khadgaClinical trials by  khadga
Clinical trials by khadgaKhadga Raj
 
Comprehensive pharmacy review
Comprehensive pharmacy reviewComprehensive pharmacy review
Comprehensive pharmacy reviewMaged Kostandy
 
Pharma intro by yousaf shah
Pharma intro by yousaf shahPharma intro by yousaf shah
Pharma intro by yousaf shahyousaf shah
 

La actualidad más candente (19)

Medication administration.ppt
Medication administration.pptMedication administration.ppt
Medication administration.ppt
 
Introduction Medication Administration
Introduction Medication AdministrationIntroduction Medication Administration
Introduction Medication Administration
 
New drug development naser
New drug development naserNew drug development naser
New drug development naser
 
New Drug Development and Review
New Drug Development and ReviewNew Drug Development and Review
New Drug Development and Review
 
Introduction to practical pharmacology
Introduction to practical pharmacologyIntroduction to practical pharmacology
Introduction to practical pharmacology
 
Basic parmacology
Basic parmacologyBasic parmacology
Basic parmacology
 
Pharmacology 1
Pharmacology 1Pharmacology 1
Pharmacology 1
 
Introduction to pharmacology 1
Introduction  to pharmacology 1Introduction  to pharmacology 1
Introduction to pharmacology 1
 
Phase clinicaltrial
Phase clinicaltrialPhase clinicaltrial
Phase clinicaltrial
 
Introduction to clinical pharmacology (RUD)
Introduction to clinical pharmacology (RUD)Introduction to clinical pharmacology (RUD)
Introduction to clinical pharmacology (RUD)
 
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
 
6 rules of drug administration
6 rules of drug administration6 rules of drug administration
6 rules of drug administration
 
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional ...
 
Introduction to pharmacology in nursing
Introduction to pharmacology in nursingIntroduction to pharmacology in nursing
Introduction to pharmacology in nursing
 
1. introduction, route of administration
1. introduction, route of administration 1. introduction, route of administration
1. introduction, route of administration
 
Clinical trials by khadga
Clinical trials by  khadgaClinical trials by  khadga
Clinical trials by khadga
 
Comprehensive pharmacy review
Comprehensive pharmacy reviewComprehensive pharmacy review
Comprehensive pharmacy review
 
Drug Discovery New Drug Development Process
Drug Discovery New Drug Development ProcessDrug Discovery New Drug Development Process
Drug Discovery New Drug Development Process
 
Pharma intro by yousaf shah
Pharma intro by yousaf shahPharma intro by yousaf shah
Pharma intro by yousaf shah
 

Destacado

Destacado (6)

Retirement Income: Which Accounts to Tap First?
Retirement Income: Which Accounts to Tap First?Retirement Income: Which Accounts to Tap First?
Retirement Income: Which Accounts to Tap First?
 
Flex new[smallpdf.com]
Flex new[smallpdf.com]Flex new[smallpdf.com]
Flex new[smallpdf.com]
 
FFD at SFE USA 2011
FFD at SFE USA 2011FFD at SFE USA 2011
FFD at SFE USA 2011
 
2ºI
2ºI2ºI
2ºI
 
Proyecto de aula
Proyecto de aulaProyecto de aula
Proyecto de aula
 
บทที่7
บทที่7บทที่7
บทที่7
 

Similar a Introduction to pharmacology

History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trialsUrmila Aswar
 
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.comDrug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.comNeelima Sharma
 
phases of a clinical trial and accelerated drug
 phases of a clinical trial and accelerated drug phases of a clinical trial and accelerated drug
phases of a clinical trial and accelerated drugSabeena Choudhary
 
Veena Sanjay Katoriya
Veena Sanjay KatoriyaVeena Sanjay Katoriya
Veena Sanjay KatoriyaVEENA18
 
Clinical Research, A Basic Understanding...........
Clinical Research, A Basic Understanding...........Clinical Research, A Basic Understanding...........
Clinical Research, A Basic Understanding...........Jobin Kunjumon Vilapurathuu
 
Phases of clinical trials
Phases of clinical trialsPhases of clinical trials
Phases of clinical trialsRavish Yadav
 
Evaluation of the evidence of the drug development
Evaluation of the evidence of the drug developmentEvaluation of the evidence of the drug development
Evaluation of the evidence of the drug developmentaJaY mIsHrA
 
investigational new drug.pptx
investigational new drug.pptxinvestigational new drug.pptx
investigational new drug.pptxTariqHusain19
 
Drug development during clinical trials.pptx
Drug development during clinical trials.pptxDrug development during clinical trials.pptx
Drug development during clinical trials.pptxKipronoKeitanyTimoth
 
Clinical trials and new drug development
Clinical trials and new drug developmentClinical trials and new drug development
Clinical trials and new drug developmentRahul Bhati
 
Clinical trials dhruva
Clinical trials dhruvaClinical trials dhruva
Clinical trials dhruvaDhruva Sharma
 
Drug development and_approval
Drug development and_approvalDrug development and_approval
Drug development and_approvalFaika Başoğlu
 
2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).ppt2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).pptaasiyahola
 
2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).ppt2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).pptaasiyahola
 
drug research.pptx
drug research.pptxdrug research.pptx
drug research.pptxVdJani
 
Unit 1 Part 1Drug Development Process - Part 1.pptx
Unit 1  Part 1Drug Development Process - Part 1.pptxUnit 1  Part 1Drug Development Process - Part 1.pptx
Unit 1 Part 1Drug Development Process - Part 1.pptxDimple Marathe
 

Similar a Introduction to pharmacology (20)

History of clinical trials
History of clinical trialsHistory of clinical trials
History of clinical trials
 
Drug designing
Drug designing Drug designing
Drug designing
 
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.comDrug discovery By  Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
Drug discovery By Neelima Sharma WCC chennai,neelima.sharma60@gmail.com
 
Clinical trials
Clinical  trialsClinical  trials
Clinical trials
 
phases of a clinical trial and accelerated drug
 phases of a clinical trial and accelerated drug phases of a clinical trial and accelerated drug
phases of a clinical trial and accelerated drug
 
Veena Sanjay Katoriya
Veena Sanjay KatoriyaVeena Sanjay Katoriya
Veena Sanjay Katoriya
 
Clinical Research, A Basic Understanding...........
Clinical Research, A Basic Understanding...........Clinical Research, A Basic Understanding...........
Clinical Research, A Basic Understanding...........
 
Phases of clinical trials
Phases of clinical trialsPhases of clinical trials
Phases of clinical trials
 
Evaluation of the evidence of the drug development
Evaluation of the evidence of the drug developmentEvaluation of the evidence of the drug development
Evaluation of the evidence of the drug development
 
investigational new drug.pptx
investigational new drug.pptxinvestigational new drug.pptx
investigational new drug.pptx
 
Drug development during clinical trials.pptx
Drug development during clinical trials.pptxDrug development during clinical trials.pptx
Drug development during clinical trials.pptx
 
Clinical trials and new drug development
Clinical trials and new drug developmentClinical trials and new drug development
Clinical trials and new drug development
 
Clinical trials dhruva
Clinical trials dhruvaClinical trials dhruva
Clinical trials dhruva
 
Drug development and_approval
Drug development and_approvalDrug development and_approval
Drug development and_approval
 
2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).ppt2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).ppt
 
2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).ppt2Clinical Trials-1(1).ppt
2Clinical Trials-1(1).ppt
 
Schedule y by dr.roohna
Schedule y by dr.roohnaSchedule y by dr.roohna
Schedule y by dr.roohna
 
Pharmacology
PharmacologyPharmacology
Pharmacology
 
drug research.pptx
drug research.pptxdrug research.pptx
drug research.pptx
 
Unit 1 Part 1Drug Development Process - Part 1.pptx
Unit 1  Part 1Drug Development Process - Part 1.pptxUnit 1  Part 1Drug Development Process - Part 1.pptx
Unit 1 Part 1Drug Development Process - Part 1.pptx
 

Último

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 

Último (20)

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 

Introduction to pharmacology

  • 1. Introduction to Pharmacology Practicum of Health Science Technology 2009 - 2010
  • 2. What is Pharmacology? • Pharmaceutical derived from the Greek word for poison • A science that studies drug effects within a living system • Deals with all drugs used in society today, legal or illegal, including street, prescription, and non- prescription or over –the-counter medications
  • 3. Drug • A drug is defined as any substance used in the diagnosis, cure, treatment, or prevention of a disease or condition
  • 4. Drug Names • Chemical Name • Generic Name • Trade Name
  • 5. Chemical Name • Describes its molecular structure and distinguishes it from other drugs
  • 6. Generic name • Determined by the pharmaceutical company along with a special organization known as the U.S. Adopted Names Council (USAN)
  • 7. Trade Name • Or brand name- the manufacturer selects alone…can become a registered trademark. They are the only one who can advertise and market the drug under that name
  • 8. How is the Trade Name Chosen? • The particular spelling of a brand name drug is proposed by a manufacturer for one of several reasons.
  • 9. 1. To indicate the disease process being treated • Azmacort- treats asthma • Rythmol- treats cardiac arrhythmias
  • 10. 2. To simplify the generic name • Pseudoephedrine to Sudefed • Haloperidol to Haldol • Ciprofloxacin to Cipro
  • 11. 3. To indicate the duration • Slow-K slow release potassium supplement
  • 12. Prescription Drugs • Or legend drugs • Means in order to obtain drug, you must have a legal prescription
  • 13. Non-Prescription Drugs • Or Over-the-Counter (OTC) drugs • Drug that may be purchased without a prescription
  • 14. Sources of Drugs Drugs and biological products have been identified or derived from four main sources: • Plants • Animals and Humans • Minerals and Mineral Products • Synthetic or Chemical Substances Made in the Laboratory
  • 15. Active Constituents of Plant Drugs • The leaves, roots, seeds, and other parts of plants may be dried or otherwise processed for use as a medicine and , as such, are known as Crude drugs. • Their therapeutic effect is produced by the chemical substances they contain
  • 16. Active Constituents of Plant Drugs • When the pharmacologically active parts are separated from the crude preparation, the resulting substances are more potent and usually produce effects more reliably than the crude drug.
  • 17. Active Constituents of Plant Drugs • Some of the types of pharmacologically active compounds found in plants, grouped according to their physical and chemical properties, are alkaloids, glycosides, gums and oils
  • 18. Alkaloids • Organic compounds that are alkaline in nature and are chemically combined with acids in the laboratory to form water – soluble salts • Example – Morphine Sulfate
  • 19. Glycosides • Active plant substances that, on hydrolysis, yield sugar plus one or more additional active substances • The sugar is believed to increase the solubility, absorption, permeability, and cellular distribution of the glycoside • Example - Digoxin
  • 20. Gums • Plant exudates • When water is added, some of them will swell and form gelatinous masses • Others remain unchanged in the GI tract, where they act as hydrophilic colloids • They absorb water, form watery bulk, and exert a laxative effect • Are also used to soothe irritated skin and mucous membranes • Example – Psyllium seeds are a natural laxative gum • Example – Carboxymethylcellulose are synthetic colloids
  • 21. Oils • Highly viscous liquids and are generally of two kinds 1. Volatile 2. Fixed
  • 22. Volatile Oil • Imparts an aroma to a plant • Because of their pleasant odor and taste, these oils are frequently used as flavoring agents • Evaporate easily • Typically non-greasy • Example – Peppermint
  • 23. Fixed Oil • Generally greasy and do not evaporate easily • Example – Castor Oil
  • 24. Drug Classification • Can be approached from two perspectives 1. Clinical Indication Example – Bronchodilator Drugs 2. Body System Example – Drugs Affecting the Nervous System
  • 25. Controlled Substances • Drugs which are classified according to their use and abuse potential • Term originated in 1970 as a result of the Controlled Substances Act which was developed to provide increased research into, and prevention of, drug abuse and drug dependence; to provide treatment and rehabilitation of drug abusers and drug dependent persons; and to improve the administration and regulation of the manufacturing, distributing, and dispensing of controlled substances
  • 26. Schedule of Controlled Substances • Classifies drugs solely according to their use and abuse potential • Drugs are classified into numbered levels, or schedules, from Schedule I to Schedule V • Drugs with the highest abuse potential are placed in Schedule I; those with the lowest potential for abuse are in Schedule V
  • 27. Investigational Drugs • The multibillion dollar pharmaceutical industry is constantly screening substances with potential to market as new drugs • Prospective drugs take anywhere from 5 – 10+ years and huge amounts of money to progress through the Food and Drug Administration required testing sequence
  • 28. Drug Design • New drugs are discovered in one of two ways 1. Totally new chemical substance 2. Derived from molecular manipulation of a current drug
  • 29. Drug Design • Until recently,designing a new drug by changing the molecular structure of an existing drug was a very slow process of trial and error
  • 30. Recombinant DNA technology Gene splicing or genetic engineering • Aided by computer design and use of enzymes, researchers are able to remove DNA chemically from one organism and transplant into other
  • 31. Testing • In vitro- in glass • In vivo- in living • Many guidelines set by FDA
  • 32. Animal Phase • Precedes human testing • Watching for toxic effects,side effects, addictions, cancerous tumors or fetal deformities
  • 33. Animal Phase • Calculating the Therapeutic Index (TI) …. The difference between the dosage that produces a Therapeutic Effect and the dosage that produces a Toxic Effect
  • 34. Animal Phase • NOT always a reliable indicator of how well a drug will perform in humans.
  • 35. Animal Phase • Modes of Absorption • Distribution • Metabolism • Excretion
  • 36. Human Testing • Occurs in three phases • All participants must be given informed consent
  • 37. Informed Consent • Written consent to an experimental procedure by an individual after he or she has been given a careful explanation of the purpose of the study, procedure to be used, the expected effects, and the risks involved
  • 38. Nuremberg Code • Developed under the guidance of American physicians as a result of the post World War II trials at Nuremberg of Nazi physicians who had conducted experiments on political prisoners without their consent
  • 39. The Code states: • Truly voluntary consent of the human subject is critical • The experiment must be proved to be valid or made possible only through the use of human subjects • The results and risks are justified by the study
  • 40. The Nuremberg Code • Unnecessary suffering, death, or disability will be avoided • The experiment will be conducted in a careful and professional manner by scientifically qualified persons • The subject or the investigator may terminate the experiment at any point that it is felt unendurable or impossible
  • 41. Human Testing: Phase I • Healthy volunteers used to study absorption, distribution, metabolism, and routes of elimination or excretion • Safe dose range, evaluate side effects and establish a correct dosage for therapeutic effect. • Blood tests, urine analysis, vital signs, and specific monitoring tests are performed during this phase
  • 42. Human Testing: Phase II • Drug is administered at gradually increasing dosages to selected individuals with the targeted disease • During this phase individuals are closely monitored for drug effectiveness and for side effects • If no serious side effects occur, the study will progress to Phase III
  • 43. Human Testing: Phase III • Drug is ready for testing at various different centers in larger numbers than previous phases • Standard protocols have been established to be followed at each center
  • 44. Human Testing: Phase III • Objectives for this phase are: - Determination of clinical effectiveness - Drug Safety determination - Establishment of tolerated dosage or dosage range
  • 45. Human Testing: Phase III • Group A • all patients with the disorder receive the new drug being studied • results compared to next two groups for side effects and ability to treat disorder
  • 46. Human Testing: Phase III • Group B • all patients have disorder meant to be treated by new drug • all patients receive a placebo and results are compared to other 2 groups
  • 47. Human Testing: Phase III • Group C • all patients have disorder meant to be treated by new drug • patients will be treated by another drug currently being used to treat disorder
  • 48. FDA Approval • After reviewing all documentation on the safety and effectiveness of the new drug • May be protected by a patent for up to 17 years
  • 49. Pregnancy Safe Categories • Before using any drug during pregnancy, the expected benefits should be considered against the possible risks to the fetus • The FDA has established a scale to indicate drugs that may have documented problems in animals and/or humans during pregnancy • For many drugs, this information is unknown
  • 50. Category A • Adequate and well – controlled studies indicate no risk to the fetus in the first trimester of pregnancy, and there is no evidence of risk in later trimesters.
  • 51. Category B • Animal reproduction studies indicate no risk to the fetus and there are no well – controlled studies in pregnant women
  • 52. Category C • Animal reproduction studies have reported adverse effects on the fetus; and there are no well – controlled studies in humans, but potential benefits may indicate use of the drug in pregnant women despite potential risks
  • 53. Category D • Positive human fetal risk has been reported in data from investigational or marketing experience, or human studies • Considering potential benefit versus risk may, in selected cases, warrant the use of these drugs in pregnant women
  • 54. Category X • Fetal abnormalities reported and positive evidence of fetal risk in humans is available from animal and/or human studies • The risks involved outweigh the potential benefits • These drugs should NOT be used in pregnant women
  • 55. Medication Orders • Verbal Order • Telephone Order • Incomplete Order • Incorrect or Inappropriate Order • Invalid Order • Orders for Unfamiliar Drugs
  • 56. Medication Order Should Include: • Name of patient medication is to be administered • Medication name • Dosage • Route • Time of administration • Signature of prescriber
  • 57. Verbal Order • Given or received verbally • All orders must be written prior to administration
  • 58. Telephone Order • An order given over the telephone • Prescriber must sign order within 48h of administration • Person receiving the orders should listen to the order, write it down, then repeat it back to the prescriber completely for verification prior to ending the call
  • 59. Incomplete Order • Orders that are not complete in patient name, medication name, dose, route, time, or signature must be clarified and corrected BEFORE administration
  • 60. Incorrect or Inappropriate Order • May be judged by the administrator as being incorrect, or inappropriate for the client it is ordered • It is the administrator’s RIGHT and RESPONSIBILITY to question ANY order or action that is potentially harmful to the patient • To carry out an order that one knows to be incorrect constitutes negligence • To change an order by modifying any part of it without the consultation with the prescriber is ILLEGAL
  • 61. Incorrect or Inappropriate Order • Validate the order by consulting an authoritative reference source such as a drug reference book • If the order is apparently incorrect, objectively report the conflicting facts and discuss it with the prescriber • If the prescriber still wants the medication given as ordered after the objections have been stated the immediate supervisors, or managers should be sought
  • 62. Incorrect or Inappropriate Order • If the prescriber decides to administer the medication themselves make sure the documentation reflects the objections and actions that have taken place
  • 63. Invalid Order • Orders signed by medical students, unlicensed interns and medical residents; and physicians who do not have prescriptive authority at your institution should not be administered until the order is verified and clarification is made
  • 64. Order for Unfamiliar Drug • Prior to administration of an unfamiliar medication, the administrator should “Look It Up” or “Ask the Pharmacists”! • Administration of an unfamiliar medication while remaining in ignorance of its actions, its intended effects and side effects, and its adverse reactions is considered negligence if it results in harm to the patient
  • 65. 5 Rights of Drug Administration 1. Right Medication 2. Right Patient 3. Right Dosage 4. Right Route 5. Right Time
  • 67. Instructions Define the following terms in your interactive note book. Utilize KIM technique with the K = Key word/ key term; I = Information/ Definition; and M = Memory Cue – something that will help you to remember the term. Maybe a picture, word, or phrase.
  • 68. Terms • Pharmacology • Alkaloid • Pharmacopeia • Glycoside • Drug • Gums • Chemical Name • Hydrophilic • Generic Name • Water – soluble • Trade Name • Volatile oil • Prescription Drug • Fixed oil • Non-prescription Drug
  • 69. Terms • Controlled • Toxic effect Substance • Alkaline • Therapeutic Index • Hydrolysis • Therapeutic effect • Distribution • Informed Consent • Metabolism • Crude drugs • Excretion
  • 71. • USAN – United States Adopted Name Council • OTC – Over – the – Counter • PDR – Physician’s Desk Reference • FDA – Food and Drug Administration • DEA – Drug Enforcement Administration • TI – Therapeutic Index • VO – Verbal order • TO – Telephone order
  • 72. VIP of the Week
  • 73. Alexander Fleming Instructions: Research this person and write the following in your interactive notebook. • Who is he? Describe him as a person. • What significance did he have to medicine, science, or health care? • How can you utilize his contribution in your profession? • How did his contribution affect the world?